JP2007526331A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007526331A5 JP2007526331A5 JP2007501990A JP2007501990A JP2007526331A5 JP 2007526331 A5 JP2007526331 A5 JP 2007526331A5 JP 2007501990 A JP2007501990 A JP 2007501990A JP 2007501990 A JP2007501990 A JP 2007501990A JP 2007526331 A5 JP2007526331 A5 JP 2007526331A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- alkyl
- alkenyl
- choh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 206010062016 Immunosuppression Diseases 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- 125000005251 aryl acyl group Chemical group 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 230000001506 immunosuppresive effect Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 claims 1
- -1 alkenyl compound Chemical class 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54976904P | 2004-03-02 | 2004-03-02 | |
| US60/549,769 | 2004-03-02 | ||
| PCT/US2005/006952 WO2005084365A2 (en) | 2004-03-02 | 2005-03-02 | Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007526331A JP2007526331A (ja) | 2007-09-13 |
| JP2007526331A5 true JP2007526331A5 (enExample) | 2008-04-17 |
| JP5057966B2 JP5057966B2 (ja) | 2012-10-24 |
Family
ID=34919536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501990A Expired - Fee Related JP5057966B2 (ja) | 2004-03-02 | 2005-03-02 | 免疫調節剤および抗癌剤としてのトリプトライドラクトン環誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7863464B2 (enExample) |
| EP (1) | EP1732536B1 (enExample) |
| JP (1) | JP5057966B2 (enExample) |
| CN (1) | CN100558354C (enExample) |
| AT (1) | ATE554758T1 (enExample) |
| AU (1) | AU2005218610B2 (enExample) |
| CA (1) | CA2557260C (enExample) |
| DK (1) | DK1732536T3 (enExample) |
| ES (1) | ES2385716T3 (enExample) |
| WO (1) | WO2005084365A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4680589B2 (ja) * | 2002-05-31 | 2011-05-11 | ファーマジェネシス， インコーポレイテッド | アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体 |
| US7820834B2 (en) | 2003-12-24 | 2010-10-26 | Pharmagenesis, Inc. | Triptolide 5,6-derivatives as immunomodulators and anticancer agents |
| EP1722806A4 (en) * | 2004-02-09 | 2009-09-16 | Pharmagenesis Inc | METHOD OF ISOLATING TRIPTOLIDE COMPOUNDS FROM TRIPTERYGIUM WILFORDII |
| ES2385716T3 (es) * | 2004-03-02 | 2012-07-30 | Pharmagenesis, Inc. | Derivados en el anillo de lactona de triptolida como inmunomoduladores y agentes anticáncer |
| US8617906B2 (en) | 2004-10-13 | 2013-12-31 | Pharmagenesis, Inc. | Identification and screening of triptolide target molecules |
| AU2010210594B2 (en) * | 2009-02-05 | 2015-02-12 | Pharmagenesis, Inc. | Triptolide C-ring derivatives as anticancer agents and immune modulators |
| US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
| MY160392A (en) | 2009-05-07 | 2017-03-15 | Univ Minnesota | Triptolide prodrugs |
| US20160038454A1 (en) * | 2013-03-15 | 2016-02-11 | Pharmagenesis, Inc. | Intravenous formulations of triptolide compounds as immunomodulators and anticancer agents |
| WO2015127011A1 (en) | 2014-02-21 | 2015-08-27 | Institute Of Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | C-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition |
| WO2016181312A1 (en) * | 2015-05-11 | 2016-11-17 | Versitech Limited | Polycyclic epoxides and compositions thereof with anti-cancer activities |
| CN107663225A (zh) * | 2016-07-29 | 2018-02-06 | 欣凯医药化工中间体（上海）有限公司 | 一种氟代雷公藤内酯醇内酯环衍生物 |
| CN106749496A (zh) * | 2016-12-05 | 2017-05-31 | 张奇军 | 新型雷公藤甲素衍生物、及其制备和用途 |
| CN108530511B (zh) * | 2017-03-02 | 2021-06-22 | 欣凯医药化工中间体（上海）有限公司 | 一种c19-酰基化雷公藤甲素衍生物 |
| CN108530510A (zh) * | 2017-03-02 | 2018-09-14 | 欣凯医药化工中间体（上海）有限公司 | 一种c19-酰基化雷公藤甲素的制备方法 |
| WO2018222351A1 (en) * | 2017-05-27 | 2018-12-06 | Pharmagenesis, Inc. | Triptolide lactone derivatives as immunomodulators and anticancer agents |
| CN109942665B (zh) * | 2018-04-02 | 2021-04-06 | 欣凯医药化工中间体（上海）有限公司 | 雷公藤内酯醇衍生物及其制备方法和应用 |
| CN110551170B (zh) * | 2018-05-31 | 2022-04-22 | 欣凯医药化工中间体（上海）有限公司 | 一种c-19位单酰基化雷公藤内酯醇衍生物的合成方法 |
| CN110551171B (zh) * | 2018-05-31 | 2021-07-27 | 欣凯医药化工中间体（上海）有限公司 | 一种雷公藤内酯醇衍生物的制备方法 |
| CN110551172B (zh) * | 2018-05-31 | 2021-08-27 | 欣凯医药化工中间体（上海）有限公司 | 一种c-19位双键化雷公藤内酯醇衍生物的合成方法 |
| CN111909119B (zh) * | 2020-08-25 | 2023-06-16 | 上海诗丹德标准技术服务有限公司 | 雷公藤来源化合物及其应用和制备方法、药物组合物、杀虫剂 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005108A (en) * | 1973-04-03 | 1977-01-25 | Research Corporation | Novel anti-leukemic diterpenoid triepoxides |
| CA1310009C (en) | 1984-03-28 | 1992-11-10 | John Mark Braughler | Ester prodrugs of steroids |
| CN1027371C (zh) | 1989-09-08 | 1995-01-11 | 中国医学科学院皮肤病研究所 | 二萜内酯化合物的合成方法 |
| US5430054A (en) | 1989-12-22 | 1995-07-04 | Jiangsu Family Planning Institute | Preparation methods of diterpene lactone compounds and application of the same to antifertility |
| CN1052859A (zh) | 1989-12-22 | 1991-07-10 | 中国医学科学院皮肤病研究所 | 17-羟基雷藤内酯醇及类似物的结构与制备方法 |
| EP0472733B1 (en) | 1990-03-06 | 1994-12-28 | Otsuka Pharmaceutical Co., Ltd. | Phenanthrene derivative |
| AU7570191A (en) | 1990-03-14 | 1991-10-10 | Board Of Regents, The University Of Texas System | Tripterygium wilfordii hook f extracts and components thereof for immunosuppression |
| US5580562A (en) | 1990-03-14 | 1996-12-03 | Board Of Regents The University Of Texas System | Preparations and uses thereof for immunosuppression |
| US5843452A (en) | 1992-11-09 | 1998-12-01 | Pharmagenesis, Inc. | Immunotherapy composition and method |
| US5468772A (en) | 1993-03-10 | 1995-11-21 | Pharmagenesis, Inc. | Tripterinin compound and method |
| US5759550A (en) | 1993-05-06 | 1998-06-02 | Pharmagenesis, Inc. | Method for suppressing xenograft rejection |
| AU6826194A (en) | 1993-05-06 | 1994-12-12 | Pharmagenesis, Inc. | 16-hydroxytriptolide composition and method for immunotherapy |
| US5919816A (en) | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| US5648376A (en) | 1995-01-19 | 1997-07-15 | Pharmagenesis, Inc. | Immunosuppressant diterpene compound |
| US5663335A (en) | 1996-03-01 | 1997-09-02 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
| US5994064A (en) | 1996-04-24 | 1999-11-30 | Identigene, Inc. | Simple and complex tandem repeats with DNA typing method |
| WO1998023281A1 (en) | 1996-11-26 | 1998-06-04 | Pharmagenesis, Inc. | ANTIFUNGAL COMPOUNDS FROM $i(PSEUDOMONAS VIRIDIFLAVA) |
| US5962516A (en) | 1997-02-28 | 1999-10-05 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
| EP0983275B1 (en) | 1997-05-23 | 2002-08-28 | Aventis Pharmaceuticals Inc. | Novel triptolide derivatives useful in the treatment of autoimmune diseases |
| US6004999A (en) | 1997-05-23 | 1999-12-21 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
| ES2213279T3 (es) | 1997-05-23 | 2004-08-16 | Aventis Pharmaceuticals Inc. | Derivados de triptolida utiles en el tratamiento de enfermedades autoinmunes. |
| US5972998A (en) | 1997-05-23 | 1999-10-26 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
| US6011042A (en) | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
| US6548537B1 (en) * | 1998-09-02 | 2003-04-15 | Pharmagenesis, Inc. | Triptolide prodrugs having high aqueous solubility |
| DE69932649T2 (de) | 1998-09-02 | 2007-08-09 | Pharmagenesis, Inc., Palo Alto | Triptolid-Prodrugs mit hoher Wasserlöslichkeit |
| US6329148B1 (en) | 1999-02-16 | 2001-12-11 | The Board Of Trustees Of The Leland Stanford University | Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells |
| AU5368699A (en) | 1999-04-16 | 2000-11-02 | Chengdu Diao Pharmaceutical Group Company Limited | Derivatives of triptolide, and preparation and uses thereof |
| US6294546B1 (en) | 1999-08-30 | 2001-09-25 | The Broad Of Trustees Of The Leland Stanford Junior University | Uses of diterpenoid triepoxides as an anti-proliferative agent |
| CN1317248A (zh) | 2000-04-13 | 2001-10-17 | 福建省医学科学研究所 | 紫雷藤杀虫剂及其制备方法 |
| US20020077350A1 (en) | 2000-08-01 | 2002-06-20 | Ashni Naturaceuticals, Inc. | Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 |
| WO2002017931A1 (fr) | 2000-09-01 | 2002-03-07 | Xiaomin Wang | Utilisation d'un ou de plusieurs extraits de tripterygium wilfordii hook.f pour la preparation de medicaments destines a prevenir et a traiter des troubles du systeme nerveux |
| AU2001296542B2 (en) | 2000-10-02 | 2007-10-25 | Emory University | Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| US6620843B2 (en) | 2001-01-19 | 2003-09-16 | Pharmagenesis | Anticancer treatment using triptolide prodrugs |
| US6569893B2 (en) | 2001-03-15 | 2003-05-27 | Pharmagenesis, Inc. | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents |
| JP4680589B2 (ja) | 2002-05-31 | 2011-05-11 | ファーマジェネシス， インコーポレイテッド | アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体 |
| US20040018260A1 (en) | 2002-06-19 | 2004-01-29 | Novemed Group Limited | Novel botanical extract of Tripterygium Wilfordii Hook F. |
| JP2006513209A (ja) | 2002-12-17 | 2006-04-20 | ファーマジェネシス， インコーポレイテッド | 免疫調節因子および抗癌剤としてのトリプトライド誘導体 |
| US6943259B2 (en) | 2003-02-25 | 2005-09-13 | Pharmagenesis, Inc. | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| WO2005020887A2 (en) * | 2003-06-27 | 2005-03-10 | Pharmagenesis, Inc. | Method for treatment of severe acute respiratory syndrome |
| US7820834B2 (en) | 2003-12-24 | 2010-10-26 | Pharmagenesis, Inc. | Triptolide 5,6-derivatives as immunomodulators and anticancer agents |
| EP1722806A4 (en) | 2004-02-09 | 2009-09-16 | Pharmagenesis Inc | METHOD OF ISOLATING TRIPTOLIDE COMPOUNDS FROM TRIPTERYGIUM WILFORDII |
| ES2385716T3 (es) | 2004-03-02 | 2012-07-30 | Pharmagenesis, Inc. | Derivados en el anillo de lactona de triptolida como inmunomoduladores y agentes anticáncer |
| WO2006012204A2 (en) | 2004-06-25 | 2006-02-02 | Pharmagenesis, Inc. | Method for treatment of inflammatory disorders using triptolide compounds |
-
2005
- 2005-03-02 ES ES05724487T patent/ES2385716T3/es not_active Expired - Lifetime
- 2005-03-02 AT AT05724487T patent/ATE554758T1/de active
- 2005-03-02 CA CA2557260A patent/CA2557260C/en not_active Expired - Fee Related
- 2005-03-02 CN CNB2005800068751A patent/CN100558354C/zh not_active Expired - Lifetime
- 2005-03-02 JP JP2007501990A patent/JP5057966B2/ja not_active Expired - Fee Related
- 2005-03-02 DK DK05724487.3T patent/DK1732536T3/da active
- 2005-03-02 AU AU2005218610A patent/AU2005218610B2/en not_active Ceased
- 2005-03-02 US US10/591,358 patent/US7863464B2/en not_active Expired - Fee Related
- 2005-03-02 WO PCT/US2005/006952 patent/WO2005084365A2/en not_active Ceased
- 2005-03-02 EP EP05724487A patent/EP1732536B1/en not_active Expired - Lifetime
-
2010
- 2010-09-02 US US12/874,434 patent/US8426616B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007526331A5 (enExample) | ||
| JP2010515731A5 (enExample) | ||
| JP2010534247A5 (enExample) | ||
| JP2010536766A5 (enExample) | ||
| JP2007269797A5 (enExample) | ||
| JP2011006405A5 (ja) | 化合物 | |
| JP2009526034A5 (enExample) | ||
| RU2008135153A (ru) | Применение нитрооксипроизводного лекарственного средства для лечения мышечной дистрофии | |
| JP2013541503A5 (enExample) | ||
| JP2013505929A5 (enExample) | ||
| JP2009256202A5 (enExample) | ||
| JP2007511546A5 (enExample) | ||
| JP2013254069A5 (enExample) | ||
| JP2008511634A5 (enExample) | ||
| JP2008208052A5 (enExample) | ||
| JP2013544276A5 (enExample) | ||
| RU2010100971A (ru) | Аминосоединение и его фармацевтическое применение | |
| JP2007302689A5 (enExample) | ||
| JP2010534246A5 (enExample) | ||
| JP2009519903A5 (enExample) | ||
| JP2014516033A5 (enExample) | ||
| JP2008512408A5 (enExample) | ||
| JP2011526252A5 (enExample) | ||
| JP2007501270A5 (enExample) | ||
| JP2023170310A5 (enExample) |